Product Information
CETIRIZINE HCL 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0517 per EA under NDC 16571040110. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 26, 2009.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571040110
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077829FDA Approved
8/26/2009
On Market Since
10/1/2009
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 5 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 21.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0517 per EA |
|---|---|
| All-time high | $0.0858 (Nov 13, 2019) |
| All-time low | $0.0382 (Nov 20, 2024) |
| 52-week high | $0.0526 |
| 52-week low | $0.0472 |
| Median price | $0.0557 |
| Average price | $0.0567 |
| Largest weekly change | +48.6% (May 22, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0517 per EA (NDC 16571040110), effective Aug 19, 2026.
How has the price of CETIRIZINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 5 MG TABLET has declined 21.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 5 MG TABLET?
Since Nov 28, 2013, the NADAC for CETIRIZINE HCL 5 MG TABLET has ranged from a low of $0.0382 (Nov 20, 2024) to a high of $0.0858 (Nov 13, 2019), with a median of $0.0557 per EA.
Are there cheaper alternatives to CETIRIZINE HCL 5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CETIRIZINE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CETIRIZINE HCL 5 MG TABLET?
CETIRIZINE HCL 5 MG TABLET (NDC 16571040110) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.